Finland – Healthcare, Regulatory and Reimbursement Landscape
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
GlobalData, the industry analysis specialist, has released its latest report, "Finland – Healthcare, Regulatory and Reimbursement Landscape". The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in Finland. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.
The Finnish healthcare system is one of the most advanced digital economies and emerging markets in the EU, focusing on Research & Development (R&D) and personalized medicine. The skilled workforce, increasing elderly population, chronic and lifestyle diseases, advanced healthcare infrastructure, and innovation-focused collaborations are the main factors driving the growth of the pharmaceutical market in Finland. The Finnish pharmaceutical market, based on pharmaceutical production value, increased from €2.03B in 2013 to €2.54B in 2018 at a Compound Annual Growth Rate (CAGR) of 4.5%. In terms of US Dollars, the market increased from $2.70B in 2013 to $3B in 2018 at a CAGR of 2.1%. It is forecast to reach about $3.47B in 2025. The medical devices market of Finland was valued at $0.89B in 2015, which increased to $1.05B in 2020 at a CAGR of 3.36%. The medical device market is expected to grow at a CAGR of 4% from $1.05B in 2020 to $1.3B in 2025.
Scope
The report provides information on the healthcare, regulatory, and reimbursement landscape in Finland, and includes:
– An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
– Profiles and SWOT analyses of the major players in the pharmaceutical market: Astellas, Pfizer, GlaxoSmithKline, Novartis, and Orion.
– Profiles and SWOT analyses of the major players in the medical device market: Medtronic, Roche Diagnostics, DePuy Synthes, Zimmer Biomet, and Revenio.
– An insightful review of the COVID-19 epidemiology, COVID-19 impact and developments in healthcare market, HealthTech landscape, reimbursement and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
– Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure and healthcare expenditure
– An overview of the opportunities for and challenges to growth in the Finland healthcare market
Reasons to Buy
This report will enhance your decision-making capability by allowing you to:
– Develop business strategies by understanding the trends shaping and driving Finnish healthcare market
– Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact Finnish healthcare market in the future
– Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
– Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership
Table of Contents
Table
Figures
Frequently asked questions
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.